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Abstract
Cadmium (Cd) transport in alveolar type II (ATII) cells has been studied using two in vitro models widely used to investigate lung
function: primary cultures of rat ATII cells and the human cell line A549. Nonlinear regression analyses of the uptake time-course of 109Cd
revealed: a zero-time accumulation, a fast process of accumulation which proceeds within minutes, and a much slower process which takes
hours. This three-step mechanism was characterized by different parameter values under dishes-or filter-growth conditions. A higher initial
uptake rate (vi) and equilibrium accumulation (Amax) of
109Cd were found in the rat ATII cells; these differences were not related to a higher
level of adsorption onto the external surface of the cell membrane. Specific transport systems of similar capacity but different affinity
(threefold higher in rat cells) were characterized. A significant transepithelial transport of 109Cd, with similar Pcoeff in both cell models, could
not be exclusively related to cellular metal release. Results on 3H-mannitol permeability together with 109Cd efflux data strongly suggest a
greater contribution of the paracellular pathways in Cd transport through A549 cell monolayers. These differences in transport properties
between the two lung cell models may modify the dose–response curve for Cd toxicity.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Relevant human exposure to cadmium (Cd) occurs via
the ingestion of food and drinking water and through the
inhalation of contaminated air. Though the main exposure
to Cd for nonsmoking people under normal conditions is
oral intake, uptake by inhalation may increase significantly
especially in specific workplaces where atmospheric Cd
levels have been shown to be rather high; Cd uptake by
inhalation can exceed that from ingestion in some indus-
trial and residential polluted areas. It is well known that
this metal is partially accumulated in the lung, and lung
toxicity includes acute inflammatory effects, chronic edema
and bronchitis, as well as cancer [1–4]. As for most toxic
substances, one determinant in Cd toxicity is its availability
for the lung as well as its bioavailability through inhalation
(that fraction of the inhaled metal that crosses the alveolar
epithelium and that is available for tissue distribution via
blood circulation). Cadmium absorption and lung deposi-
tion vary with the inhaled particle size; it has been shown
that particle deposition in the alveoli remains significant
for diameters smaller than 2–3 Am, whereas particles of
larger diameters deposit preferentially in the naso-pharyng-
ial region of the respiratory tract [5]. Also, it is now well
recognized that bioavailability of the inhaled metal, as well
as Cd toxicity, vary considerably with the chemical species
of concern, namely Cd speciation. Cadmium chloride,
sulfide and oxide are the most relevant metal compounds
for human exposure, particularly the two latter for occupa-
tional exposure. However, both Cd oxide and sulfide are
rather insoluble in water and Cd sulfide bioavailability has
been suggested as being very low [6].
The lung epithelium represents the first barrier to be
crossed by the inhaled metal but also the first target organ
following metal inhalation. The adult pulmonary epithelium
is composed of two cell types that are specialized for distinct
functions. Type I cells, which represent about 95% of the
alveolar surface, are spread cells, whereas type II cells are
polarized and develop microvilli at their apical domain faced
to the alveoli with tight junctions between them. Type II cells
are responsible for surfactant synthesis and storage in lamel-
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lar bodies, express numerous polarized transport systems,
and have been shown to have an important role in pulmonary
fluid clearance [7,8]. Most of the cyt. P450 activity of the
lung has been attributed to this cell type [9]. It is also known
that following lung injury with significant type I cell
necrosis, type II cells proliferate and, by undergoing a ‘‘de-
differentiation’’ or a ‘‘trans-differentiation’’ process, cover
the injured alveolar surface [10]. Controversy still exists on
whether or not type II cells represent the stem cells for type I
cells, but it is well known that cell types are present at a
constant ratio [11].
In an attempt to better understand pulmonary Cd cytotox-
icity, studies investigating parameters that may modulate cell
sensitivity have been conducted in primary cultures of rat
type II cells as well as in the human lung carcinoma cell line
A549, which has been shown to express numerous features of
the normal type II cells including surfactant synthesis [12,13],
expression of cyt. P450 isozymes [14], cation transporters
and amiloride-sensitive Na + channels [15,16], as well as
choline transport mechanisms [17]. Most of these studies
have focused on the role of intracellular protective com-
pounds such as metallothionein (MT) and reduced gluta-
thione (GSH) [18–20] but few have been devoted to the
mechanisms of transport into and across the alveolar cells.
Moreover, rat alveolar type II (ATII) and A549 cells represent
two in vitro models widely used to investigate alveolar cell
function but we do not know to what extent the results for Cd
obtained in the cell line compared with data in rat cells. We
have therefore characterized Cd uptake in A549 cells as well
as in primary cultures of type II cells isolated from rat. The
main goals of our study were: (i) to compare kinetic param-
eter values for Cd uptake in the two alveolar cell models, and
(ii) to evaluate the respective contribution of paracellular and
transcellular pathways in the transepithelial transport of Cd
through ATII cell monolayers. These points are critical
determinants of the pulmonary absorption and lung toxicity
of the inhaled metal. Our results point out similarities and
differences between the two cell models: higher initial uptake
rate (vi) and equilibrium accumulation (Amax), higher affinity
(lower Km value) as well as a higher contribution of the
transcellular pathways to Cd transport through cell mono-
layers in rat ATII cells compared to the human A549 cell line.
They also show that although cell monolayers form barriers
relatively resistant to mannitol, paracellular pathways may
contribute to significant transepithelial transport of Cd.
2. Materials and methods
2.1. Cell culture
2.1.1. Cell line A549
Cell line A549, obtained from the American Type Culture
Collection, was maintained in Ham’s F12 medium (50 units/
ml penicillin, 50 Ag/ml streptomycin) supplemented with
10% heat-inactivated fetal bovine serum (FBS) and 1 mM
glutamine. Cells were routinely grown in 75-cm2 culture
flasks at 37 jC in a 5% CO2–95% humidified air atmosphere
and were passaged weekly by trypsinization (0.05% trypsin–
0.053 mM EDTA). For all the experiments, cells were seeded
at 12.5 103 cells/cm2 in 35-mm diameter petri dishes
(Falcon) or in tissue-treated polyester membranes (Costar
Transwell-Clear cell culture inserts), 24-mm diameter, 0.4-
Am pore size. Cell cultures were maintained for 14 days
(most of studies showing that A549 cells express an ATII-
like phenotype were carried out on post-confluent cultures)
and the culture medium was changed every 2 days. Cells
were used between passages 79 to 85.
2.1.2. Primary culture of rat ATII cells
ATII cells were isolated from male Sprague–Dawley rats
according to the method of Dobbs et al. [21]. Briefly,
perfused lung was digested with elastase and the ATII cells
were purified by differential adherence on bacteriological
plastic dishes coated with rat IgG. The cells were main-
tained in MEM medium (0.2% NaHCO3, 0.01 M HEPES,
80 Ag/l gentamicin) supplemented with 10% FBS and 2 mM
glutamine. Cells were seeded at 2 105 cells/cm2 in 24-
mm-diameter six-well plates (Falcon) and were maintained
only for 3 days at 37 jC in a 5% CO2–95% humidified air
atmosphere to avoid the well known transdifferentiation to
the ATI phenotype occurring by day 4 or 5 [22–24].
2.2. Accumulation and transport measurements
Cellular Cd accumulation and transcellular transport
experiments were performed at room temperature on 14-
day-old A549 and 3-day-old type II cell monolayers, grown
on petri dishes or microporous membranes in a defined
transport medium containing (in mM): 137 NaCl, 5.9 KCl,
1.2 MgSO4, 2.5 CaCl2, 4 D-glucose and 10 HEPES, adjusted
to pH 7.3 by addition of 5 mM NaOH. The monolayers were
washed four times with 2ml (Petri dishes or AP side) and 3ml
(BL side) of 109Cd-free transport medium in order to remove
the serum-containing culture medium. Accumulation was
started by incubating the cells in 2 ml (petri dishes or AP
exposure) transport medium containing 0.3 AM of 109Cd-
labeled CdCl2 (sp. act. from 0.24 to 0.33 mCi/Amol). In some
cases, experiments were carried out in the presence of various
concentrations of unlabeled Cd used as a pure competitive
inhibitor [25,26]; in all cases, values of accumulation are
reported relative to tracer 109Cd exclusively. Mannitol trans-
port experiments were performed as in Cd transport measure-
ments using an exposure medium containing 0.3 AM of 3H-
labeled mannitol (sp. act. 19.03 Ci/mmol).
Tracer accumulation was stopped by removing the trans-
port medium, and the monolayers were rapidly rinsed four
times with 2 ml (petri dishes or AP side) and 3 ml (BL side)
of ice-cold 109Cd-free (or 3H-mannitol-free) transport
medium in order to remove the excess radioactivity. In
some experiments, these rinses were performed with 2
mM EDTA-containing stop solution (Ca2 + -, Mg2 + -free)
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to extract the external labile metal fraction from the cell
surface. Cells from dishes were then solubilized in 1 N
NaOH (0.5 ml) and aliquots of 0.3 ml were used for
radioactivity determination using a gamma counter (Cobra
II, Canberra Packard Canada), while 50 Al of the remaining
suspension was kept for protein assay. For experiments
performed on cells grown on microporous membranes, 1
ml of the BL medium was retained before the filters were
carefully cut off from the inserts. Cells and media samples
were then used for radioactivity determination. Cells from
three monolayers of the same subculture were washed with
PBS, harvested and pooled together for protein determina-
tion. In the present paper, accumulation refers to the total
amount of 109Cd measured in cell samples (adsorption + up-
take), uptake data correspond to the metal that actually
crosses the cell membrane (accumulation– adsorption),
whereas adsorption refers to the metal bound to the cell
surface (accumulation—uptake), namely the EDTA-sensi-
tive labile component of accumulation. On the other hand,
transport data (transepithelial transport) refer to the total
amount of 109Cd tracer (or 3H-mannitol) that crosses the
monolayers and that is recovered in the BL medium
following AP exposure. Both accumulation and transport
are expressed as pmol 109Cd (or 3H-mannitol) per mg
protein, the amount of tracer transported being calculated
for the total volume (3 ml) of the medium in the BL
compartment.
2.3. Cadmium efflux measurements
Cadmium efflux measurements were performed at room
temperature on 14-day-old A549 and 3-day-old type II cell
monolayers grown on microporous membranes. The cells
were first exposed on the AP side to 0.3 AM 109Cd for 1 h, at
which time accumulation processes were stopped as
described in the previous section, but using room-temper-
ature stop solution. The cells were then incubated in 2-ml
(dishes and AP compartment) or 3-ml (BL compartment)
109Cd-free medium. At specific times of efflux, 1 ml of both
the AP and the BL media were sampled and the cells were
washed rapidly with ice-cold stop solution. The filters were
then excised from the inserts, and samples of the cells and the
media were used for radioactivity determinations. EDTA-
containing solutions were not used as the efflux medium
since the lack of Ca2 + in such media might be expected to
disrupt the intercellular tight junctions, leading to artifactual
paracellular leakage.
2.4. Data analyses
2.4.1. Accumulation studies
Nonlinear regression analyses of the accumulation (A)
time-course data obtained over a 12-h exposure were
performed using first-order rate Eq. (1)
A ¼ AeðfÞð1 ekAðf ÞtÞ þ AeðsÞð1 ekAðsÞtÞ þ A0 ð1Þ
in which A0 represents the zero-time accumulation value,
Ae(f) and Ae(s) stand for the equilibrium accumulation
values achieved with rate constants kA(f) and kA(s), respec-
tively.
Accumulation (and uptake) data obtained under initial
rate (zero-trans) conditions were analysed according to
linear Eq. (2)
A ¼ vt þ A0 ð2Þ
in which the initial rate v of accumulation (uptake) is the
slope of the regression line.
2.4.2. Efflux studies
Nonlinear regression analyses of the efflux (E) time-
course data were performed using first-order decay Eq. (3)
E ¼ ðE0  EeÞekEt þ Ee ð3Þ
in which E0 represents the cellular accumulation of
109Cd at
time t= 0 of efflux, and Ee stands for the plateau of efflux
reached with the first order rate constant kE. Data obtained for
the cellular 109Cd released (R) in the AP or the BL compart-
ment were analysed according to first-order rate Eq. (4)
R ¼ Reð1 ekRtÞ ð4Þ
in which Re stands for the maximal amount of Cd that it is
recovered in the efflux medium with the rate constant kR.
For all time-course studies, the t1/2 values reported in this
paper represent the time for which processes are half-com-
pleted. Their numerical values were calculated using Eq. (5)
t1=2 ¼ ln2
k
ð5Þ
in which k represents any of the rate constants estimated in
Eqs. (1)–(4).
2.4.3. Kinetic parameter determinations
Kinetic data of 109Cd accumulation obtained by one-time
point measurements at 1 min were analyzed using the
modified Michaelis–Menten Eq. (6)
v ¼ VmaxT
Km þ T þ S þ kDT ð6Þ
in which Km and Vmax have their usual meaning, and T and S
stand for tracer (0.3 AM) and unlabeled Cd concentrations
(0–1000 AM), respectively. As previously discussed, kD,
which represents all nonspecific contributions to the uptake,
is considered as an operational parameter only [25].
2.4.4. Permeability coefficient determinations
The apparent permeability coefficients for 109Cd and 3H-
mannitol were determined according to Eq. (7)
Pcoeff ¼ dQ
dt
1
ACAP
ð7Þ
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where dQ/dt is the steady state flux (mol/s), CAP is the initial
apical concentration (mol/ml), and A is the surface area of
the membrane (4.52 cm2).
All nonlinear regression analyses of the uptake, efflux
and kinetics data, as well as linear regression analyses of the
uptake data obtained in short-time experiments, were per-
formed using Enzfitter (Robin J. Leatherbarrow, Copyright
n 1987) and Prims3 (GraphPad software, Inc, Copyright n
2001) software. The errors associated with the kinetic
parameter values given in the text represent the standard
errors of regression (SER).
2.5. Materials
All culture ware (Falcon) was obtained from VWR Sci-
entific (Toronto, Ont.). Minimal essential and Ham’s F-12
media, penicillin, gentamicin, streptomycin and trypsin were
purchased from Gibco BRL (Grand Island, NY), whereas
Fig. 1. Time-course of 0.3 AM 109Cd accumulation in 3-day-old rat ATII cells (A) and 14-day-old A549 cells (B) grown on petri dishes. Accumulation
measurements were performed as described in the text. Points shown are meansF S.D. evaluated on three different cell cultures. The lines shown are the best-
fit curves over the data points as obtained according to the first-order rate Eq. (1). The uptake parameters are listed in Table 1. Insets: 1-h time-course of tracer
accumulation.
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FBS was obtained from Medicorp Inc. (Montre´al, QC).
Glutamine and Rat Ig-G were obtained from Sigma Chemical
Co. (St. Louis, MO), whereas elastase was purchased from
Worthington (Lakewood, NJ). Labeled 109CdCl2 and
3H-
mannitol were obtained from Dupont Canada Inc. (Missis-
sauga, ON), and unlabeled CdCl2 from Sigma. All salts and
chemicals used for buffer preparation were ACS reagents or
of higher purity.
3. Results
3.1. Kinetic characteristics of Cd uptake
The time-courses of 0.3 AM 109Cd accumulation in the
rat ATII (Fig. 1A) and the A549 cells (Fig. 1B) grown on
petri dishes could both be well analyzed according to the
first-order rate Eq. (1) which describes a zero-time (A0), a
fast (Af) and a slow (As) process of accumulation, the latter
being responsible for most of the maximal cellular accumu-
lation (insets allow a better view of the 1-h time-courses). It
clearly appears that the rat ATII cells accumulate much
higher levels of 109Cd compared to the A459 cells, with the
following differences: (i) a 2.5-fold higher A0 value; and (ii)
a near 10-fold higher equilibrium accumulation is obtained
for both the fast and the slow processes (Ae(f) and Ae(s) in
Table 1). Interestingly, no significant differences could be
observed between the t1/2 values, showing that similar
periods of time are needed for each process of accumulation
to be completed in both cell samples.
The observed differences between equilibrium accumu-
lation values may be underestimated. Indeed, considering an
average cell density of 0.4F 0.05 and 0.9F 0.1 mg/dish for
the ATII and the A549 cells, respectively, the mean accu-
mulation values of 666F 23 and 80F 3 pmol/mg protein
obtained following a 12-h exposure represent a cellular
109Cd content of 266F 16 and 72F 12 pmol per petri dish,
which is about 44% and 12% of the total tracer initially
present in the uptake medium (600 pmol/2 ml). These
estimates compared quite well with direct measurements of
109Cd concentration in the transport medium following a 12-h
exposure of the cell samples. Indeed, decreases of 39% (0.183
vs. 0.300 AM) and 16% (0.253 vs. 0.300 AM) in tracer levels
were recorded for the ATII and the A549 cells, respectively.
Rapid tracer depletion from the uptake medium may contrib-
ute, in part, to the leveling off in 109Cd accumulation; thus the
Ae(f) and Ae(s) values may be underestimated, especially for
the rat ATII cells. Nevertheless, from a qualitative point of
view, accumulation parameter values reported in Table 1
clearly reveal that 109Cd accumulates much more in the rat
type II cells than in the cell line.
In order to discriminate between uptake into the cells and
adsorption onto the cell surface, cellular 109Cd levels were
also measured in cell samples washed with a 2 mM EDTA-
containing stop solution. For a 15-min exposure, the adsorp-
tion contribution to the total metal accumulation was 19%
and 7% in rat ATII (Table 2) and A549 (Table 3) cells,
respectively; this contribution of adsorption decreased rap-
idly for longer periods of exposure. Note that even for short
exposure times, the differences observed between accumu-
lation (obtained with standard rinses) and uptake data
(obtained with EDTA rinses) were not statistically signifi-
cant. Consequently, the higher accumulation values obtained
in the rat type II cells cannot be related to higher levels of
adsorption.
3.2. Initial uptake rate of specific and nonspecific transport
of Cd
The initial rate (v) of tracer accumulation/uptake has been
compared in both cell models following very short exposure
times. Because 109Cd accumulation could be approximated
by straight lines only up to 4- and 2-min incubation for the
rat and the A549 cells, respectively (data not shown), the
initial rate of tracer accumulation/uptake was estimated over
Table 1
Parameter values describing the time-course of 109Cd accumulation aver a 12-h exposure in primary culture of rat alveolar type II cells and in the A549 cells
A0 (pmol/mg protein) Ae(f) (pmol/mg protein) t1/2(f) (min) Ae(s) (pmol/mg protein) t1/2(s) (h)
Rat ATII 23.3F 3.8 132F 13 5.9F 1.2 839F 178 11.5F 3.6
A459 8.9F 1.0 12.9F 0.9 4.3F 0.8 90F 15 8.9F 2.2
Experimental conditions and analyses were as described in the legend to Fig. 1 showing the time-course of accumulation of 0.3 AM 109Cd in alveoar type II
cells isolated from rats and in the A549 cells. The meaning of the parameters (A0, Ae(f), Ae(s), t1/2(f) and t1/2(s)) is given in the text. The values shown are the best-
fit parametersF SER values corresponding to Eq. (1).
Table 2
Tracer levels measured in rat alveolar type II cells grown on petri dishes
following exposure to 0.3 AM 109Cd for different times with respect to
different washing solutions
Time Std
(pmol/mg protein)
EDTA
(pmol/mg protein)
EDTA-sensitive
(%)
15 min 116F 10 94F 6 18.9
30 min 136F 12 123F 7 9.6
1 h 187F 18 165F 15 11.7
3 h 308F 15 279F 13 9.4
6 h 407F 16 398F 18 2.2
9 h 535F 17 519F 11 2.9
12 h 581F 24 569F 30 2.1
Following exposure for the desired time, cells were rapidly rinsed in the
absence (Std) or in the presence (EDTA) of 2 mM EDTA added in the cold
stop solution. Consequently, the relative percentage of EDTA-sensitive
labile fraction of 109Cd accumulation has been calculated as explained in
the text.
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a 3-min and a 1-min period of exposure to 0.3 AM 109Cd in
the primary cultures (Fig. 2A) and the cell line (Fig. 2B),
respectively. The data points obtained under various exper-
imental conditions have been analyzed according to Eq. (2),
and the parameter values are reported in Table 4. Data
obtained using a standard stop solution (filled circles) reveal
that 109Cd is accumulated in the rat ATII cells about four
times as fast as in the A549 cells (v = 24.2F 1.7 vs.
5.7F 0.6 pmol/min/mg protein). Note, however, that the
EDTA washing procedure (filled squares) leads to an appa-
rent decrease of 26% in the initial rate of tracer accumu-
lation in the rat ATII cells but not in the A549 cells,
although no significant effect of EDTA rinses could be
detected following longer exposure times (Table 2). Because
the EDTA-sensitive component of tracer accumulation is
believed to represent rapid adsorption and is not expected to
increase with time, these results strongly suggest that a rapid
efflux may occur during the washing step with EDTA in the
rat ATII cells but not in the A549 cells.
Measurements performed in the presence of an excess of
300 AM unlabeled Cd (open circles), used as a specific
inhibitor, reveal a specific (vS, displaceable) and a non-
specific (vNS, non displaceable) component of v. Only 10%
and 14% of the total v is nonspecific in the primary cultures
and the cell line, respectively. This nonspecific process of
accumulation can easily be related to the diffusional com-
ponent (kD[
109Cd]). Now, if we assume that 300 AM
unlabeled Cd completely inhibits the specific accumulation
of 0.3 AM tracer, from the vNS values of 2.5F 0.3 and
0.8F 0.2 pmol/mg obtained in the rat ATII and the A549
cells, kD values of 8.3F 1 and 2.7F 0.7 pmol/min/AM/mg
protein can be estimated for each cell sample, respectively.
Thus, passive diffusion led to a threefold faster Cd accu-
mulation in the rat ATII cells compared to the cell line. Note
that in all cases of co-incubation with tracer and unlabeled
Cd, data obtained following rinses with a standard or a 2
mM EDTA-containing stop solution were not significantly
different (data not shown). Fig. 2 also shows the presence of
a nonzero intercept value on the y axis, part of which is
specific (A0S), as revealed by its sensitivity to unlabeled Cd.
From the parameter values reported in Table 4, it can be
estimated that 70% and 49% of A0 is specific for the rat ATII
and the A549 cells, respectively. On the other hand, the part
of A0 that still remains in the presence of unlabeled Cd may
represent rapid nonspecific adsorption and/or unwashed
tracer, namely dead space (A0NS). In accordance with this,
EDTA-containing stop solution decreased but did not com-
pletely eliminate A0 in both cell models. From the A0NS
values of 4.8F 0.4 and 2.3F 0.2 pmol/mg obtained for 0.3
AM tracer in the rat ATII and the A549 cells, Kd values of
16F 1.3 and 7.7F 0.7 pmol/AM/mg protein can be esti-
mated for each cell sample, respectively. A twofold higher
Table 3
Tracer levels measured in A549 cells grown on petri dishes following
exposure to 0.3 AM 109Cd for different times with respect to different
washing solutions
Time Std
(pmol/mg protein)
EDTA
(pmol/mg protein)
EDTA-sensitive
(%)
15 min 28F 6 26F 4 7.1
30 min 35F 7 36F 9 –
1 h 44F 11 41F10 6.8
3 h 56F 9 53F 9 5.3
6 h 64F 13 66F 10 –
9 h 78F 18 75F 8 3.8
12 h 97F 19 100F 13 –
Following exposure for the desired time, cells were rapidly rinsed in the
absence (Std) or in the presence (EDTA) of 2 mM EDTA added in the cold
stop solution. Consequently, the relative percentage of EDTA-sensitive
labile fraction of 109Cd accumulation can has been calculated as explained
in the text.
Fig. 2. Effect of an excess of unlabeled Cd (300 AM) in the transport
medium or 2 mM EDTA in the stop solution on short-term cellular
accumulation of 0.3 AM 109Cd. Three-day-old rat ATII cells (A) and 14-
day-old A549 cells (B) grown on petri dishes were exposed to tracer in the
absence of unlabeled Cd and washed with standard (filled circles) or EDTA-
containing (filled squares) stop solution or exposed to tracer in the presence
of unlabeled Cd and washed with a standard stop solution (open circles).
Values shown are the meansF S.D. evaluated in five determinations of the
same subculture. The parameters obtained following linear regression
analyses over the data points (Eq. (2)) are listed in Table 4.
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nonspecific initial binding is observed in the rat type II cells.
Now it appears that Kd and kD should both be considered as
part of the total nonspecific accumulation of tracer.
3.3. Kinetic parameters of Cd accumulation
The transport mechanism involved in Cd accumulation in
each cell model was further characterized by determining
the kinetic parameters by one-time point analysis, measur-
ing the initial 1-min accumulation of 0.3 AM 109Cd [T] in
the presence of increasing concentrations of unlabeled Cd
[S]. The data points obtained for the rat type II cells (Fig.
3A) and the A549 cells (Fig. 3B) could be well analyzed
according to the modified Michaelis–Menten Eq. (6) with
the following kinetic parameter values: for the ATII cells,
Vmax = 873F 109 pmol/min/mg protein, Km = 6.4F 1.3 AM,
KD = 23.6F 1.8 pmol/min/AM/mg protein; for the A549
c e l l s , Vm a x = 798 F 97 pmo l /m i n /mg p r o t e i n ,
Km = 19.3F 1.5 AM, KD = 6.7F 1.4 pmol/min/AM/mg pro-
tein. Note that KD values are in accordance with previous
estimated values ([Kd + kD]) in Fig. 2. A 3.5-fold higher
proportionality constant KD was determined for the non-
specific contributions to the total 1-min accumulation of Cd
in the rat cells. Therefore, the part of KD that represents
passive diffusion (kD) as well as the much higher specific
uptake rate (vS, Table 4) determined for Cd accumulation in
the rat ATII cells may well account for the much higher
levels of accumulation obtained in this cell model compared
to the cell line.
3.4. Transepithelial transport of Cd
Because lung absorption involves Cd passage across the
alveolar epithelium, the accumulation and transepithelial
transport of 0.3 AM 109Cd have also been studied in cell
monolayers grown on filters, a culture system allowing
access to the basolateral (BL) as well as to the apical (AP)
side of the cells. Results of this study are shown in Fig. 4. In
both cell models, the accumulation time-course of 109Cd
(filled circles) could be well analyzed according to Eq. (1)
but different parameters were obtained compared to petri-
dish culture conditions. Much lower levels of accumulation
were recorded under filter-growth conditions for the rat ATII
cells (Ae(f) f 70vs. 130pmol/mgprotein;Ae(s) f 600vs. 840
pmol/mg protein) but comparable t1/2 values were estimated
(t1/2(f) f 7 vs. 6 min; t1/2(s) f 13 vs. 11 h) (Fig. 4A). For
109Cd accumulation in the A549 grown on filters (Fig. 4B),
and contrary to what has been observed with cells grown on
petri dishes, the fast process of accumulation, but not the
slow one, was found responsible for most of the maximal
cellular accumulation (Ae(f) f 55 vs. 13 pmol/mg protein;
Ae(s) f35 vs. 90 pmol/mg protein). Therefore, although t1/2
values were similar whatever the culture conditions (t1/2(f)
f 6 vs. 4 min; t1/2(s) f 6 vs. 9 h), the accumulation time-
course of 109Cd was clearly different in A549 cells grown
on filters.
In both cell models, 109Cd was highly transported across
the cell monolayers (open triangles); an apparent Pcoeff
value of 67 10 7 and 46 10 7 cm/s could be estimated
for the rat and the A549 cells, respectively (average cell
density of 0.3 and 0.8 mg/filter for the primary culture and
the cell line, respectively). Interestingly, the accumulation
and transport time-courses were found parallel in ATII cell
monolayers; a constant ratio of cellular-to-basolateral 109Cd
level (decreasing only from 1.8 to 1.3 between 1 and 12 h of
exposure) was measured during the period of time studied.
In contrast, transport across the A549 cells increased sig-
nificantly after the cellular accumulation had plateaued; the
ratio of cellular-to-basolateral tracer level decreased dramat-
ically from 2.2 to 0.7 during the 12-h period studied.
Now, considering an average cell density of 0.3 mg/filter
for the rat ATII cells, cellular Cd accumulation of about 402
pmol/mg protein recorded following a 12-h exposure to 0.3
AM 109Cd can be converted tof 121 pmol/filter. Similarly,
Table 4
Specific, nonspecific and EDTA-sensitive zero-time intercept A0 and initial rate v of accumulation
Conditions Zero-time intercept (pmol/mg protein) Initial rates (pmol/min/mg protein)
A0 A0S AEDTA v vS vEDTA
Rat ATII
Ctrl 16.1F1.6 11.3F 2.0 8.3F 2.6 24.2F 1.7 21.7F 2.0 6.4F 2.0
EDTA 7.8F 1.0 – – 17.8F 1.1 – –
Cd 48F 0.4 – – 2.5F 0.3 – –
A549
Ctrl 4.5F 0.4 2.2F 0.6 1.2F 0.7 5.7F 0.6 4.9F 0.8 NIL
EDTA 3.3F 0.3 – – 6.0F 0.4 – –
Cd 2.3F 0.2 – – 0.8F 0.2 – –
Experimental conditions and analyses were as described in the legend to Fig. 2. Values shown are the best-fit parametersF SER obtained by linear regression
analyses of the data recorded for the rat type II alveolar cells (Fig. 2A) and the A549 cells (Fig. 2B). The parameters A0 and v represent the intercept and the
slope of the regression lines, respectively. Specific A0S and vS fractions were calculated by subtraction of the total values obtained in the presence of 300 AM
unlabeled Cd (Cd) from the total values estimated under control conditions (Ctrl, 0.3 AM 109Cd alone). EDTA-sensitive fractions AEDTA and vEDTA were
calculated by subtraction of values measured following washing procedure using 2 mM EDTA from the respective values measured with standard 109Cd-free
stop solution.
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the AP-to-BL transport value of 308 pmol/mg protein can be
converted to 92 pmol/filter. Thus, 213 pmol (121 + 92 pmol)
of tracer would be lost from the AP medium within 12 h.
Considering an initial amount of 600 pmol (2 ml of 0.3 AM),
AP Cd concentration fell to 0.194 AM (600–213 pmol/2 ml)
after 12 h. Similarly, and considering an average cell density
of 0.8 mg/filter for the A549 cells, the residual AP level of
109Cd can be estimated to 0.198 AM (600–204 pmol/2 ml)
after 12 h. These estimates agree with direct measurements
of Cd level in the AP medium following a 12-h exposure
Fig. 3. Determination of kinetic parameters for 109Cd influx in 3-day-old rat ATII cells (A) and 14-day-old A549 cells (B) grown on petri dishes. Initial
accumulation values were estimated by one-time point analysis (1 min) as described in the text using a tracer 109Cd concentration of 0.3 AM and unlabeled Cd
concentrations ranging from 0 to 1000 AM. Values shown are the meansF S.D. evaluated in five determinations of the same subculture. The lines shown are
the best-fit curves to Eq. (6) with the following kinetic parameter values: (A) Km= 6.4F 1.3 AM, Vmax = 873F 109 pmol/min/mg protein, KD = 23.6F 1.8
pmol/min/AM/mg protein; (B) Km= 19.3F 1.5 AM, Vmax = 798F 97 pmol/min/mg protein, KD = 6.7F 1.4 pmol/min/AM/mg protein. Insets: the log scale on
the x axis allows a better presentation of the kinetic data.
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(0.178 and 0.187 AM for the rat ATII and the A549 cells,
respectively).
3.5. Kinetics of Cd efflux
The transepithelial transport of Cd may be the result of
important transcellular (cellular metal release in the BL
medium) and/or paracellular pathways (leakage through
tight junctions). To estimate the relative contribution of
the transcellular pathways in the transepithelial transport
of Cd, the time-course of cellular 109Cd efflux was studied
following a 1-h preincubation at 0.3 AM 109Cd on the apical
(AP) side (Fig. 5). For both cell models, cellular tracer
efflux data (filled circles) could be well analyzed according
to the first-order decay Eq. (3). Parameter values reported in
Table 5 reveal a rapid process of efflux in both cell models
(parameters t1/2E ) but most of the
109Cd remained in the
cells, especially for the A549 cells (parameters Ee relative to
E0). Indeed, the estimated relative amounts of
109Cd lost
([E0Ee]/Ee 100) are 52% and 35% for the rat ATII and
the A549 cells, respectively. These results, together with the
data reported in Table 2, reveal that Cd efflux cannot be
exclusively attributed to metal desorption from the cell
surface.
In parallel to the measurements of cellular 109Cd contents,
the amount of tracer recovered in either the AP or the BL
medium was also recorded during the efflux studies. Data
obtained could be well analyzed according to the first order
rate Eq. (4). The parameter values reported in Table 6 reveal
that tracer is significantly recovered in the AP (filled trian-
gles) as well as in the BL (open triangles) compartment.
However, tracer levels in AP medium were twice that in the
BL medium for both cell models; two thirds of the total
Fig. 5. Kinetics of 109Cd efflux from 3-day-old rat ATII cells (A) and 14-
day-old A549 cells (B) grown on filters and preexposed to 0.3 AM 109Cd on
the apical side for 1 h. Cellular 109Cd release (filled circles) and the
concomitant appearance of tracer in the apical (filled triangles) and the
basolateral (open triangles) medium were recorded as described in the text.
Lines show the best fit-curves through the data points (the meansF S.D.
evaluated on three different cell cultures) corresponding to the first-order
decay Eq. (3) (cellular release) and to the first-order rate Eq. (4) (tracer
appearance in the efflux media). The efflux parameters are listed in Tables 5
and 6.
Fig. 4. Time-course of 0.3 AM 109Cd cellular accumulation and trans-
epithelial transport in 3-day-old rat ATII cells (A) and 14-day-old A549
cells (B) grown on filters. Cells were exposed to tracer on the apical side
and cellular level (filled circles), and total amounts of tracer recovered in
the basolateral chamber of the inserts (open triangles) were measured as
explained in the text. Values shown are the meansF S.D. evaluated in three
determinations of different cultures. The lines shown are the best-fit curves
through data points, as obtained according to Eq. (1).
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109Cd lost from the cell was recovered in the AP compart-
ment. Also, the appearance of tracer in the BL medium
occurred much more slowly than Cd release from the AP side
of the cell monolayers (compare parameter t1/2R values for
AP and BL recovery in Table 6).
3.6. Monolayers permeability properties
Efflux studies strongly suggest that transcellular path-
ways, although being significant, are not mainly responsible
for the high level of 109Cd transported across cell mono-
layers. The paracellular pathways were thus investigated by
measuring monolayers permeability to 3H-mannitol. The
transport time-course of 0.3 AM 3H-mannitol from the AP
to the BL medium (Fig. 6A) clearly shows that the A549
cell monolayers (filled circles) are much more ‘‘leaky’’ than
the primary cultures (open circles). Indeed, from initial (30
min) transport measurements, an apparent Pcoeff value of
3 10 7 and 29 10 7 cm/s can be estimated for the
ATII and the A549 cell monolayers, respectively. Moreover,
nonlinear regression analysis of the data point according to
Eq. (4) (where R is changed to T: transport, and t1/2R to t1/2T)
reveal a sevenfold higher equilibrium transport value for the
cell line compared to the primary cultures (118F 11 vs.
16F 1 pmol/mg protein). Note that the 3H-mannitol content
in cell monolayers remained negligible in both cell samples
(Fig. 6B); clearly, dead space does not contribute appreci-
ably to the cellular 109Cd accumulation estimated previously
(Figs. 1 and 4).
4. Discussion
4.1. Higher levels of Cd accumulation as well as initial
uptake rate in the rat ATII cells
The pulmonary toxicity of Cd has been largely studied
using primary cultures of rat ATII cells as well as the human
cell line A549. However, very few investigations have been
devoted to the mechanisms of Cd transport into alveolar
cells. Here we show that Cd accumulation in both cell
models involves a three-step mechanism. Indeed, data
Table 6
Parameters describing the time-course of 109Cd appearance in the AP and
BL compartments during the cellular tracer release
Re (pmol/mg protein) t1/2R (min)
Rat ATII
AP 76.8F 3.0 2.5F 0.4
BL 30.4F 1.0 4.1F 0.5
A549
AP 26.2F 1.3 5.2F 0.9
BL 13.3F 1.8 11.6F 3.7
Experimental conditions and analyses were as described in the legend to
Fig. 4 showing the efflux time-course of 109Cd following a 1-h
preincubation with 0.3 AM 109Cd. The meaning of the parameters Re, and
t1/2R is given in the text. Values shown are the best-fit parametersF SER
obtained by regression analyses of the data recorded for the rat type II
alveolar cells and the A549 cells according to Eq. (4).
Fig. 6. Time-course of 0.3 AM 3H-mannitol transepithelial transport (A) and
monolayer accumulation (B) in 3-day-old rat ATII cells (open circles) and
14-day-old A549 cells (filled circles) grown on filters. Cells were exposed
to tracer on the apical side, and the cellular level as well as total amounts of
tracer recovered in the basolateral chamber of the inserts were measured as
explained in the text. Values shown are the meansF S.D. evaluated in five
determinations of the same subcultures. The lines shown are the best-fit
curves through data points, as obtained according to Eq. (4).
Table 5
Efflux parameters describing the time-course of cellular 109Cd release
E0 (pmol/mg protein) Ee (pmol/mg protein) t1/2E (min)
Rat ATII 201F10 96.4F 3.5 1.3F 0.3
A549 65.5F 2.3 42.5F 1.2 3.1F 0.8
Experimental conditions and analyses were as described in the legend to
Fig. 4 showing the efflux time-course of 109Cd following a 1-h
preincubation with 0.3 AM 109Cd. The meaning of the parameters E0, Ee
and t1/2E is given in the text. Values shown are the best-fit parameters
F SER obtained by regression analyses of the data recorded for the rat type
II alveolar cells and the A549 cells according to Eq. (3).
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obtained over a 12-h exposure were analyzed according to
Eq. (1) describing: (1) a zero-time accumulation that shows
up as a nonzero intercept (A0 in Figs. 1 and 2); (2) a fast
process of accumulation Af, which proceeds within minutes;
(3) a much slower process As, which takes hours (Table 1).
Each of these steps gives much higher levels of uptake in
the rat ATII cells compared to the A549 cell line. The
EDTA-sensitive labile fraction of accumulation was found
negligible in both cell models: Cd accumulates into the
alveolar cells and the much higher uptake levels measured
in the primary cultures cannot be related to higher level of
adsorption onto the external surface of the cell membrane
(Tables 2 and 3). Our results also show that, although no
significant differences could be observed between the t1/2
values of each process of accumulation (Table 1), Cd is
taken up much more rapidly in the rats ATII (Fig. 2). This
more rapid accumulation could be related to higher initial
uptake rate for specific (vS) as well as for nonspecific (vNS
or kD) transport of Cd in the primary cultures (Table 4).
The Cd accumulation time-course has been studied in the
T27 clone of the A549 cells; no equilibration in cellular Cd
level could be observed for up to 8 h exposure to 5 AM
109Cd, although accumulation values of 0.5 Amol/109 cells
were measured [19]. Considering an average cell content of
2.3 106 cells/dish and an average cell density of 0.9 mg/
dish in our studies, the uptake value of f 67 pmol/mg
protein obtained following an 8-h exposure to 0.3 AM 109Cd
can be converted to f 26 pmol/106 cells or 0.026 Amol/109
cells. Interestingly, a comparison with uptake values
obtained by Kang et al. [19] reveals a direct correlation
between cellular Cd accumulation and the exposure con-
centration (0.5 and 0.026 Amol/109 cells following an 8-h
exposure to 5 and 0.3 AM 109Cd, respectively) although
differences in Cd uptake levels have been reported between
subpopulations of A549 cells [27]. Note that, in accordance
with previous studies showing no significant cytotoxicity in
a rat cell line that resembles ATII cells following an 8-h
exposure to 50 AM Cd or less [20], cell viability was not
affected by 0.3 AM Cd up to 12 h (data not shown). Also,
our experimental conditions are not expected to modify
cellular thiol levels nor to induce any stress proteins since
exposure to 5 AM CdCl2 up to 8 h did not succeed in
reducing GSH content [28] nor in stimulating HSP 72
synthesis in the A549 cells [29].
4.2. Specific system of higher affinity for CD in the rat ATII
cells
Specific systems of transport of similar capacity but
different affinities (threefold higher for the rat ATII cells)
were characterized for Cd accumulation in the two cell
models: for the ATII cells, Vmax = 873F 109 pmol/min/mg
protein, Km = 6.4F 1.3 AM; KD = 23.6F 1.8 pmol/min/AM/
mg protein; for the A549 cells, Vmax = 798F 97 pmol/min/
mg protein, Km= 19.3F 1.5 AM, KD = 6.7F 1.4 pmol/min/
AM/mg protein. The Km values predict 98% and 96%
inhibition of the specific 1-min accumulation of 0.3 AM
109Cd by 300 AM unlabeled Cd in the rat ATII and the A549
cells, respectively, in agreement with the results reported in
Table 4. Saturation for 109Cd transport in the A549 cells has
also been observed by Kang et al. [19]; a half-maximal
accumulation was noted for f 2.5 AM with no evidence for
any nonspecific component. However, direct comparison
with our results is difficult since these authors have consid-
ered the 8-h accumulation values. As explained earlier, they
did not observe any equilibration in Cd accumulation during
this time of exposure, whereas in our studies, initial uptake
rate conditions, namely linearity of the uptake-time course,
are only 2 min. Future studies testing, for example, inhib-
ition by other metals and/or well known inhibitors specific
to transport systems, should give insights into the transport
mechanisms responsible for Cd uptake/efflux in alveolar
lung cells. It should be noted that although kinetic data did
not reveal any heterogeneity, more than one of the Cd species
present in the exposure medium (Cd2 + , CdCln
2 n) may
conceivably participate in the transport process [30].
Now, considering that the specific uptake at t= 0 (A0S), as
well as the true specific initial uptake rate (vS) both
contribute to the 1-min accumulation (A1), the following
equality then holds (Eq. (8))
A1 ¼ A0S þ vS1 ð8Þ
in which vS1 is equivalent to vS normalized to 1-min uptake.
Because data analysis failed to detect the presence of more
than one Michaelis–Menten component, the respective
contribution of A0S and vS1 to A1 measured at any
109Cd
concentration should be directly proportional to their max-
imum values. Since the data reported in Table 4 show that
A0S and vS1 account, respectively, for 34% and 66% of the
total 1-min uptake, a A(0)max of f 297 pmol/mg protein and
a V(1)max value of f 576 pmol/mg protein can be estimated
for Cd accumulation in the rat ATII cells. Similarly, a A(0)max
of f 247 pmol/mg protein and a V(1)max value of f 551
pmol/mg protein can be estimated for the cell line.
4.3. Significant contribution of paracellular pathways to the
transepithelial transport of Cd
The time-course of accumulation and transport of 109Cd
through cell monolayers grown on filters revealed a sig-
nificant transepithelial transport in both cells models.
These results contrast with our previous data obtained in
Caco-2 cells under similar conditions showing that trans-
epithelial transport of Cd in this human intestinal cell line
never exceeds 3% of the cellular accumulation [26]. High
Pcoeff values (46–67 10 7 cm/s) have been determined
for Cd permeability in rat ATII and A549 cell monolayers,
a result in accordance with the reported high bioavailabil-
ity of the inhaled metal in animal models [31,32]. Some
studies have revealed that Cd may rapidly disrupt the
paracellular barrier without causing a significant loss of
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viability: (i) exposure to 20–60 AM Cd decreased the
TEER value in the LLC-PK1 kidney cells [33]; (ii) a 4-h
exposure to Cd concentrations higher than 25 AM
increased the Pcoeff to mannitol and PEG-4000 and sig-
nificantly reduced the TEER values in the Caco-2 intesti-
nal cells [34]. Accordingly, the fact that 0.3 AM Cd (Figs.
1 and 4) may affect the permeability of rat ATII or A549
cell monolayers exposed for 12 h cannot be excluded.
Although much less probable because of the very short
exposure time, Cd up to 1000 AM may conceivably
modify the paracellular barrier, thus increasing its own
transport. However, Cd accumulation data as well as the
kinetic parameter values are not expected to be much
affected in the case of the disruption of junction proteins
since most of our results strongly suggest that dead space
(including intercellular space) does not contribute appreci-
ably to the cellular accumulation estimation.
Now, considering an initial amount of 600 pmol in the
AP medium and the AP-to-BL transport values of 92 and
120 pmol/filter measured after 12 h for the ATII and the
A549 cells, respectively, it appears that 15% and 20% of the
metal is transported across the cell monolayers after 12 h.
However, it clearly appears that the Cd concentration in the
BL medium remains much lower compared the AP level.
Indeed, considering that 92 pmol (for ATII cells) and 120
pmol (for A549 cells) were recovered in a total BL volume
of 3 ml, tracer BL concentrations of 0.030 and 0.049 AM
can thus be estimated. Comparison with the estimated
residual concentration of Cd in the AP medium (0.194
and 0.198 AM for the ATII and the A549 cells, respectively)
clearly reveals no equilibration for Cd between the two
compartments, which argues against the possibility of a
complete paracellular barrier disruption under our experi-
mental conditions. Interestingly, a 12-h exposure resulted in
similar Cd depletion from the AP medium in the two cell
models but the respective contribution of the cellular accu-
mulation and the transepithelial transport varied with respect
to the cell samples: in the rat ATII cells, 57% and 43% of
tracer depletion was related to the cellular accumulation and
the transport across cell monolayers, respectively, whereas
these contributions were estimated to be 41% and 59%,
respectively, in the A549 cells.
Efflux studies performed following preloading of cells
for 1 h at the apical side revealed that only half and one third
of the accumulated metal is released out of the ATII and the
A549 cells, respectively. A higher percentage of Cd reten-
tion is expected for a pre-exposure time sufficiently long to
induce synthesis of cysteine-rich proteins, thus increasing
the overall cell capacity to bind Cd. Indeed, studies have
reported that a 12-h and an 8-h exposure to 10 AM Cd
significantly increased the MT mRNA and protein level in
A549 and rat ATII cells, respectively [19,20]. Interestingly,
some of these studies also reported no significant change in
Cd accumulation after cell treatment with BSO (DL-buthio-
nine-sulfoximine) or DEM (diethyl maleate) used to modify
cellular GSH and MT levels, suggesting that these peptides
would not necessarily represent the major binding sites for
intracellular Cd.
About one third of the metal lost is recovered in the
basolateral medium. These results contrast with our previous
data obtained in Caco-2 cells showing that metal efflux in the
basolateral medium following cell preexposure on the apical
side remained negligible [26]. Contribution of transcellular
pathways to the transepithelial transport of Cd is much more
important for alveolar cell monolayers compared to intestinal
cell monolayers. However, these pathways are not mainly
responsible for the high level of 109Cd transported across cell
monolayers. Unfortunately, we were not able to detect any
significant transepithelial electrical resistance (TEER) across
rat ATII or A459 cell monolayers, an observation that has also
been reported by others [14]. Numerous studies have shown
that the A549 cells express various junctional (including ZO-
1, JAM and E-cadherin) and basement membrane proteins
[35–37]. In spite of these features, very few investigators
have been able to measure a significant TEER value for
confluent A549 cell monolayers [38,39], whereas TEER
values up to 2000 V cm2 have been reported for primary
cultures of ATII cells [40]. It has been suggested that ATI and
ATII cells in vivo may form tighter monolayers than in vitro
system. Here, we found that, Pcoeff for mannitol was higher in
the A549 cell monolayers compared to the primary cultures
(29 vs. 3 10  7 cm/s) although similar values were
obtained for 109Cd permeability in both cell models. How-
ever, these results agree with data showing a higher trans-
epithelial transport of 109Cd (Fig. 4) but a lower cellular tracer
efflux in the cell line (Fig. 5). The contribution of the
paracellular pathways to the transepithelial transport of Cd
would be higher for the A549 cells, whereas that of the
transcellular pathways would be more important for the rat
ATII cells. Interestingly, maximal transport value estimated
for the A549 cells does not predict any equilibration for 3H-
mannitol between the two compartments (AP and BL). These
results suggest that A549 cell monolayers are not fully leaky,
an observation that supports other data showing that A549
cells do form barriers relatively resistant to Lucifer yellow
[14]. However, the A549 cell monolayers would not be as
tight as the primary cultures: an apparent BL-to-AP ratio of
1:10 but only 1.6:300 could be estimated for the 3H-mannitol
concentration at equilibrium for the A549 and the ATII cell
monolayers, respectively.
5. Conclusions
We have shown that high levels of Cd accumulate in the
ATII phenotype but Cd transport was much more rapid and
led to higher levels of accumulation in the primary cultures
of rat ATII cells compared to the human A549 cell line.
These differences could not be attributed to a higher level of
adsorption onto the external surface of the cell membrane in
the rat ATII cells. In both cell models, a specific system of
transport could be characterized with a threefold higher
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affinity for Cd in the rat ATII cells. Cadmium influx was
found to be only partially reversible, with about half and one
third of the accumulated metal remaining in the rat ATII and
the A549 cells, respectively, most probably tightly bound to
intracellular compounds. Although confluent cell mono-
layers were found not to be fully leaky for both cell models,
A549 cell monolayers showed greater permeability to man-
nitol; accordingly a significant transepithelial transport was
observed for Cd in this cell model. Also, we have demon-
strated that although two lung cell models may have similar
Pcoeff values for Cd, different contributions of the para- and
transcellular pathways may be significant. These differences
in transport properties may modify the dose–response curve
for Cd toxicity, the limit of extrapolation taken into account
when evaluating metal transport and/or toxicity using these
two cell models.
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